INTECH Investment Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,057
Closed -$55.6K 2492
2025
Q1
$55.6K Buy
3,057
+1,126
+58% +$32.2K ﹤0.01% 2417
2024
Q4
$71.6K Buy
1,931
+461
+31% +$17.6K ﹤0.01% 2277
2024
Q3
$47K Buy
+1,470
New +$81.6K ﹤0.01% 1986

Other funds holding CDLX

INTECH Investment Management's CDLX Position: Q2 2025 in Review

INTECH Investment Management sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 3,057 shares — an estimated $55.6K sold.

INTECH Investment Management first reported a position in CDLX in Q3 2024 and held it in 3 quarters. The position peaked at $71.6K in Q4 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • INTECH Investment Management reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • INTECH Investment Management sold 3,057 Cardlytics shares in Q2 2025, an estimated $55.6K.
  • INTECH Investment Management first reported a position in Cardlytics in Q3 2024 and held it in 3 quarters.
  • INTECH Investment Management's Cardlytics position peaked at $71.6K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.